ASTM plans to promote a classification guide for medical grade polymers, with disclosure, sterilization, and quality requirements as the core

The draft standard focuses on three dimensions. According to PlasticsToday, ASTM is advancing a draft standard for a classification guide for medical grade polymers. The core chapters of this draft provide regulations on disclosure, sterilization, and quality requirements, with the aim of clarifying what kind of polymer is eligible to be called a “medical grade polymer”. The report points out that these three parts together form the basis for determining the classification guidelines. From the disclosed framework, the draft does not simply provide a label, but attempts to establish a verifiable classification logic: materials need to disclose their composition and sources, demonstrate their ability to withstand established sterilization processes, and meet corresponding quality requirements. These three are interrelated and indispensable.

The significance of the polymer additive industry

The definition of medical grade polymers is never just a matter of the resin itself.

. Polymers undergo multiple stresses such as heat, oxygen, and radiation during processing and terminal sterilization, and their ability to maintain performance largely depends on the formulation system. Antioxidants are used to inhibit thermal oxidative degradation during processing and use, while light stabilizers and UV absorbers are related to the durability of materials under light conditions. When the classification guidelines require material disclosure of composition and proof of sterilization suitability, the types, amounts, and migration behavior of these polymer additives will naturally enter the examination field. For additive suppliers, this means that downstream medical customers will further increase their requirements for product information transparency. Functional masterbatch, as a common form of additive delivery, also falls within the scope of disclosure of its carrier resin and additive ratio; Compatible and coupling additives such as maleic anhydride grafted wax may affect interfacial bonding in filling, reinforcing, or blending systems, and may also be required to provide more complete technical specifications due to formulation disclosure requirements. In other words, although the medical grade classification guidelines focus on polymers, their compliance pressure will propagate upstream along the formula chain.

Industry impact and observation points

This standard is still in the draft stage, and the report has not disclosed specific details of the terms, effective timetable, or scope of application.

. For polymer additive companies, it is worth noting to what extent the disclosure requirements will be refined – whether they only require the declaration of the category of additives, or whether they need to provide data on migration, precipitation, or residual after sterilization. This will directly affect the selection logic and document preparation cost of components such as antioxidants and light stabilizers in medical formulas. In addition, the requirement for sterilization adaptability may drive the adjustment of auxiliary systems towards radiation resistance and low precipitation, and the demand for the development and validation of related functional masterbatch products is expected to increase. But the above impacts depend on the final text of the draft, and it is not appropriate to make excessive inferences at this stage. It is recommended that additive and masterbatch suppliers continue to track the public progress of the ASTM draft and proactively review their own product composition disclosure and sterilization compatibility information to address any new inquiries from medical customers.

Information source:Inside the Proposed Medical-Grade Polymer Classification Guide， Organized by Herun Chemical.